Losartan Potassium
Product Images NDC 53002-3638

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-3638). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530023638)

FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

FDA Label Image

Losartanfigure2 (Losartanfigure2)

Losartanfigure2 (Losartanfigure2)
The given text is showing the result of a study where the adjusted risk reduction is 26% and the p-value is 0.001. The rest of the text seems to be an axis labeled with study months and percentage of patients with a certain medical condition. Therefore, the given text could be describing the findings of a medical study that shows a significant risk reduction in a particular medical condition over the study months.*
FDA Label Image

Losartanfigure3 (Losartanfigure3)

FDA Label Image

Losartanfigure4 (Losartanfigure4)

Losartanfigure4 (Losartanfigure4)
The given text is describing the percentage of patents that have an event related to risk reduction. The value of this percentage is 18.1%, which is shown next to the text "0022". The text "Months" suggests that this data may relate to a specific time period, but no further information is available.*
FDA Label Image

Losartanstructure (Losartanstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.